Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10003229103
Persistent link: https://www.econbiz.de/10002176183
Persistent link: https://www.econbiz.de/10003387405
Persistent link: https://www.econbiz.de/10012104749
Persistent link: https://www.econbiz.de/10001710816
Persistent link: https://www.econbiz.de/10002138827
Persistent link: https://www.econbiz.de/10003878247
The pharmaceutical industry is a textbook example of a science based sector characterized by high R&D cost, uncertain and spillovers for which patent protection assures appropriability thus providing incentives for innovation. Indeed, Mansfield (1986) found that, absent patent protection, 60...
Persistent link: https://www.econbiz.de/10014216850
This paper advances an argument in support of technologyspecific tailoring of incentives to innovate. With a focus on patent incentives, the argument proceeds from the identification of the factors likely to have a bearing on (a) the differential role and effectiveness of patents in different...
Persistent link: https://www.econbiz.de/10012775583
In the New Property Rights model ownership of assets should be assigned to the most capable agents. While, in a world of incomplete contracts, the application of the model to IPRs provides insights on the nature of their second best allocation, also the opposite direction of causation may arise:...
Persistent link: https://www.econbiz.de/10014110734